Update on HIV infection: A report from CROI 2019

R. Bhatia, W. El Atrouni, F. N.U. Shweta, J. Zeuli, Stacey Rizza, Zelalem Temesgen

Research output: Contribution to journalArticle

Abstract

The 2019 Conference on Retroviruses and Opportunistic Infections (CROI 2019) was held March 4-7, 2019, in Seattle, Washington. Important research on all aspects of HIV was presented and discussed. Highlights include introduction of candidate drugs in new classes of antiretrovirals, long-acting antiretrovirals and insights from expansion of pre-exposure prophylaxis in various settings.

Original languageEnglish (US)
Pages (from-to)385-396
Number of pages12
JournalDrugs of the Future
Volume44
Issue number5
DOIs
StatePublished - Jan 1 2019

Keywords

  • Fostemsavir
  • GS-6207
  • GSK-2838232
  • Leronlimab
  • Long-acting antiretroviral drugs
  • Pre-exposure prophylaxis (PrEP)

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Update on HIV infection: A report from CROI 2019'. Together they form a unique fingerprint.

  • Cite this